Cargando…

Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians

Detalles Bibliográficos
Autores principales:	Wang, Bei, Goh, Yun Shan, Fong, Siew-Wai, Young, Barnaby Edward, Ngoh, Eve Zi Xian, Chavatte, Jean-Marc, Salleh, Siti Nazihah Mohd, Yeo, Nicholas Kim-Wah, Amrun, Siti Naqiah, Hor, Pei Xiang, Loh, Chiew Yee, Lee, Chia Yin, Chan, Yi-Hao, Chang, Zi Wei, Tay, Matthew Zirui, Rouers, Angeline, Torres-Ruesta, Anthony, Carissimo, Guillaume, Soh, Mun Kuen, Lee, Raphael Tze Chuen, Xu, Yani, Pada, Surinder, Lin, Raymond Tzer Pin, Leo, Yee-Sin, Lye, David C., Maurer-Stroh, Sebastian, Ng, Lisa F.P., Renia, Laurent, Wang, Cheng-I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450274/ https://www.ncbi.nlm.nih.gov/pubmed/34568853 http://dx.doi.org/10.1016/j.lanwpc.2021.100276

Ejemplares similares

Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection
por: Tay, Matthew Zirui, et al.
Publicado: (2022)

Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave
por: Goh, Yun Shan, et al.
Publicado: (2023)

Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant
por: Tay, Matthew Zirui, et al.
Publicado: (2023)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
por: Goh, Yun Shan, et al.
Publicado: (2022)

Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB
por: Chang, Zi Wei, et al.
Publicado: (2023)

Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
por: Renia, Laurent, et al.
Publicado: (2022)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
por: Goh, Yun Shan, et al.
Publicado: (2022)

Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore
por: Wang, Bei, et al.
Publicado: (2021)

Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19
por: Goh, Yun Shan, et al.
Publicado: (2021)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
por: Amrun, Siti Naqiah, et al.
Publicado: (2020)

Malaria abrogates O’nyong–nyong virus pathologies by restricting virus infection in nonimmune cells
por: Torres-Ruesta, Anthony, et al.
Publicado: (2022)

Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections
por: Goh, Yun Shan, et al.
Publicado: (2022)

Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients
por: Ong, Sean Wei Xiang, et al.
Publicado: (2021)

Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant
por: Lee, Cheryl Yi‐Pin, et al.
Publicado: (2021)

Systematic analysis of disease‐specific immunological signatures in patients with febrile illness from Saudi Arabia
por: Kam, Yiu‐Wing, et al.
Publicado: (2020)

B-cell ELISpot assay to analyze human memory B cell and plasmablast responses specific to SARS-CoV-2 receptor-binding domain
por: Rouers, Angeline, et al.
Publicado: (2023)

Novel differential linear B‐cell epitopes to identify Zika and dengue virus infections in patients
por: Amrun, Siti Naqiah, et al.
Publicado: (2019)

Novel differential linear B‐cell epitopes to identify Zika and dengue virus infections in patients
por: Amrun, Siti Naqiah, et al.
Publicado: (2020)

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection
por: Fong, Siew-Wai, et al.
Publicado: (2021)

Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2
por: Chan, Yi‐Hao, et al.
Publicado: (2021)

Correction to: Robust Virus‐Specific Adaptive Immunity in COVID‐19 Patients with SARS‐CoV‐2 Δ382 Variant Infection
por: Fong, Siew‐Wai, et al.
Publicado: (2021)

Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals
por: Lim, Jackwee, et al.
Publicado: (2021)

Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients
por: Poh, Chek Meng, et al.
Publicado: (2020)

Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19
por: Carissimo, Guillaume, et al.
Publicado: (2020)

Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study
por: Young, Barnaby E, et al.
Publicado: (2020)

Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate
por: Chan, Yi‐Hao, et al.
Publicado: (2019)

Virus infection drives IL-2 antibody complexes into pro-inflammatory agonists in mice
por: Lee, Wendy W. L., et al.
Publicado: (2016)

Plasmodium co-infection protects against chikungunya virus-induced pathologies
por: Teo, Teck-Hui, et al.
Publicado: (2018)

Type I interferon shapes the quantity and quality of the anti‐Zika virus antibody response
por: Lee, Cheryl Yi‐Pin, et al.
Publicado: (2020)

Tumor-mediated microbiota alteration impairs synaptic tagging/capture in the hippocampal CA1 area via IL-1β production
por: Zhu, Ying, et al.
Publicado: (2023)

Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
por: Kuramochi, Taichi, et al.
Publicado: (2022)

Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
por: Young, Barnaby E, et al.
Publicado: (2021)

Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections
por: Kam, Yiu-Wing, et al.
Publicado: (2017)

Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019
por: Ong, Sean Wei Xiang, et al.
Publicado: (2020)

Occurrence of 4 Dengue Virus Serotypes and Chikungunya Virus in Kilombero Valley, Tanzania, During the Dengue Outbreak in 2018
por: Chipwaza, Beatrice, et al.
Publicado: (2020)

Organ‐specific immune response in lethal SARS‐CoV‐2 infection by deep spatial phenotyping
por: Balachander, Akhila, et al.
Publicado: (2022)

Increased Loading, Efficacy and Sustained Release of Silibinin, a Poorly Soluble Drug Using Hydrophobically-Modified Chitosan Nanoparticles for Enhanced Delivery of Anticancer Drug Delivery Systems
por: Kuen, Cha Yee, et al.
Publicado: (2017)

Immunological observations and transcriptomic analysis of trimester‐specific full‐term placentas from three Zika virus‐infected women
por: Lum, Fok‐Moon, et al.
Publicado: (2019)

Multimodal assessments of Zika virus immune pathophysiological responses in marmosets
por: Lum, Fok-Moon, et al.
Publicado: (2018)

High Yield of HIV Testing in Dengue-Like Febrile Illness in Singapore
por: Verrall, Ayesha J, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nb2759ktd93fr4gmaoamu2pnn5